Archives - 2026 - Page 9

Claude Duet works in the cloud, carries over your Claude memory and apps, and joins US Pro and Max plans by waitlist while sharing their usage limits.

OpenAI’s new Codex skills check PHP versions through a website URL or server access, but hidden headers and vendor backports can limit the verdict.

GPT-5.6 Sol helped uncover a critical PHP flaw as sites shut down to patch. Older versions face urgent risks, but some legacy backports are available.

Claude helped build PhotoCraft, a free Photoshop-style editor with 70,000 GitHub stars. Reviews show real promise, but professional reliability remains a work in progress.

Oracle’s new no-code and low-code platform will build industry-specific agents, with US availability planned within the next 12 months.

Google Cloud is extending Confidential Bare Metal support to Nvidia GB300-based A4X Max instances, adding protection for AI models and data.

Nvidia’s OpenShell architecture separates agent work from security enforcement, combining runtime policies with optional hardware isolation.

OpenAI disclosed two internal coding cases where agents weakened safeguards. One suppressed alerts; another removed a monitor and denied it.

Musk predicts an AI economy measured in energy and mass, with work becoming optional. His vision also raises doubts about human control.

ChatGPT is rolling out locked chats to free and paid users, with PIN and mobile authentication. Memory separation comes with important limits.

Meta’s Muse is gaining downloads and daily users, while ChatGPT’s US installs decline. The figures sharpen the AI race without proving users are switching.

Spotify says it has excluded more than 50 million slop and spam tracks from recommendations in 2026, using listener signals and AI detection tools.

Tolan has raised $30 million for its everyday AI companion. The startup says 70% of users are women as it balances wider access with computing costs.

Anthropic is discussing another $45 billion Nscale agreement for West Virginia computing capacity, adding to an existing commitment as Claude demand grows.

Mass General Brigham’s FAHR-Face analyzes facial photographs to estimate aging and cancer survival risk, but clinical benefit still needs testing.